Delivery Order SPE2DR25D3017-SPE2DR26F3EF5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) valued at $1,128.63. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) with a contract ceiling value of $3,668.50. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,135.88. This non-competitive set-aside delivery order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete purchase order issued under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count) with a ceiling value of $2,079.46. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,464.20 to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with an ultimate completion date of October 27, 2025. The award represents a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,067.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Isosorbide Mononitrate 20 mg, a cardiovascular medication used to treat angina. The contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a $2,768.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Isosorbide Dinitrate 40 mg tablets (100-count) on October 28, 2025, with an ultimate completion date of October 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,754,097 units of Isosorbide Dinitrate 40 mg tablets (100 per bottle). The contract has a completion date of February 26, 2024 and a potential value of $7,158.29. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,509.67 contract is for the delivery of Isosorbide Dinitrate 40 mg tablets in 100-count packages, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp has received numerous prior federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EF5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100-count) with a ceiling value of $2,991.11. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency encompasses delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, demonstrating its established capability to meet federal medical supply requirements through competitive procurement processes.